Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION

https://doi.org/10.17749/2070-4909.2015.8.1.003-006

Full Text:

Abstract

The article sets out the results of analysis of existing models of risk sharing agreements, which are used in foreign countries at reimbursement of costs for public drug supply. The author estimates the opportunities to use risk sharing agreements in theRussian Federation, taking into consideration the existing legislative environment. The role of medical technologies evaluation system is regarded as one of the elements of decision system, which element is necessary for introduction of risk sharing agreements. The article also proposes the specific amendments to applicable law, which are to be made for successful introduction of risk sharing agreement in theRussian Federation

About the Author

L. S. Melnikova
Research Financial Institution of the Ministry of Finance of the Russian Federation, Moscow
Russian Federation

Mel'nikova Lyubov' Sergeevna – MD, leading research fellow of Research Financial Institution of the Ministry of Finance of theRussian Federation. Address: Nastasyinsky per., 3-2,Moscow, 127006,Russia. Tel.: +74956998965. E-mail: lavrinenko-irina@mail.ru.



References

1. Report on the results accessibility evaluation of medicinal preparations on basis of the analysis of consumer prices and of pricing on medicinal preparations in the Russian Federation (including in the sectional view of subjects of the Russian Federation) and on comparable markets of the countries, incl incoming in the CIS, the European Union and BRICS, FAS Russia, 2013 [Doklad o rezul'tatakh otsenki dostupnosti lekarstvennykh preparatov na osnove analiza potrebitel'skikh tsen i tsenoobrazovaniya na lekarstvennye preparaty v Rossiiskoi Federatsii (v t.ch. v razreze sub"ektov Rossiiskoi Federatsii) i na sopostavimykh rynkakh stran, v t.ch. vkhodyashchikh v SNG, Evropeiskii soyuz i BRIKS, FAS Rossii, 2013] URL http://www.fas.gov.ru/analyticalmaterials/analytical-materials_31072.html.

2. Omel'yanovskii V.V., Sura M.V., Gerasimova K.V., Avksent'eva M.V., Tatarinov A.P. Assessment of the necessary financial costs medicinal maintenance of patients with rare diseases in Russia. Newsletter. Expert Health Council of the Federation Council Committee on Social Policy of the Federal Assembly of the Russian Federation, 2014 [Otsenka neobkhodimykh finansovykh zatrat na lekarstvennoe obespechenie bol'nykh s redkimi zabolevaniyami v RF. Informatsionnyi byulleten'. Ekspertnyi sovet po zdravookhraneniyu komiteta Soveta Federatsii po sotsial'noi politike Federal'nogo Sobraniya RF, 2014 g].

3. Farrakhov A.Z., Omel'yanovskii V.V., Sisigina N.N. Nauchnoissledovatel'skii finansovyi institut. Finansovyi zhurnal. 2015; 1: 5-16.

4. Fedyaev D.V., Maksimova L.V., Omel'yanovskii V.V. Meditsinskie tekhnologii. Otsenka i vybor. 2014; 3: 25-31.

5. Fedyaev D.V., Maksimova L.V., Omel'yanovskii V.V. Meditsinskie tekhnologii. Otsenka i vybor. 2014; 2: 42-54.

6. Fedyaev D.V., Fedyaeva V.K., Omel'yanovskii V.V. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2014; 4: 3-10.

7. Chubarova T.V. Raskhody na lekarstvennoe obespechenie v stranakh OESR: sovremennoe sostoyanie i tendentsii. Nauchnoissledovatel'skii finansovyi institut. Finansovyi zhurnal. 2014; 3: 47-58.

8. ISPOR TASK FORCE REPORTS. Performance-Based RiskSharing Arrangements – Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for PerformanceBased Risk-Sharing Arrangements Task Force. 2013; 32.

9. McCabe C.J., Stafinski T., Edlin R., Menon D. Access with evidence development schemes: a framework for description and evaluation. Pharmacoeconomics. 2010; 28: 143-52.


For citation:


Melnikova L.S. PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2015;8(1):3-6. (In Russ.) https://doi.org/10.17749/2070-4909.2015.8.1.003-006

Views: 512


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)